Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Natural Human Interferon Alpha Administered Oromucosally in the Treatment of Oral Warts in HIV-seropositive Subjects Receiving Combination Anti-retroviral Therapy: A Phase 2 Clinical Trial

NCT00454181 is registered in ClinicalTrials.gov with Ainos, Inc. (f/k/a Amarillo Biosciences Inc. as lead sponsor.

NCT NCT00454181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00454181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Natural Human Interferon Alpha Administered Oromucosally in the Treatment of Oral Warts in HIV-seropositive Subjects Receiving Combination Anti-retroviral Therapy: A Phase 2 Clinical Trial
Lead sponsor
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2007
Completion date
October 31, 2009
Enrollment
59 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, papillomatosis